SYDNEY, Feb 4 (Bernama-GLOBE NEWSWIRE) — George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs).
The addition of this capability means that George Clinical can now, under the Gene Technology Act 2000 and Gene Technology Regulations 2001, undertake DIR (dealings involving intentional release) and DNIR (dealings not involving intentional release) licensing and execute studies inclusive of the required writing of DIR and DNIR applications as well as IBC (Institutional Biosafety Committee) review. Being OGTR accredited enables George Clinical to hold a license in the name of a sponsoring company.
- 170 Afghan Inmates Set Free From Pakistan, Iraq
- Pakistan, Afghanistan Agreed To Immediate Ceasefire In Doha Talks
- Iran’s IRGC Unveils Upgraded Ballistic Missiles, Overhauled Launchers
- Netanyahu To Run For PM Again In Israel’s 2026 Elections
- Hamas Said Rafah Closure To Delay Handover Of Israeli Hostage Remains; Palestinian Death Toll: 68,116
- Pakistan’s Airstrike Kills 17 Civilians In E. Afghanistan
- Over 70 Terrorists Killed As Pakistan Airstrikes Afghan Border Areas: Pakistani Army
- One Suspected Rebel Slain In Clash With Philippine Military
- Thai PM Pledges To Enhance All-Round Cooperation With China
- Mongolian Parliament Passed Resolution To Dismiss PM